Journal ArticleOPEN ACCESS

Thwarting galectin-induced immunosuppression in breast cancer

OncoImmunology (2013) 2(5)
DOI: 10.4161/onci.24077
5Citations
Citations of this article
18Readers
Mendeley users who have this article in their library.

This article is free to access.

Abstract

Novel therapeutic strategies are needed to counteract breast cancer-associated immunosuppression. Silencing the expression of galectin-1 in a breast carcinoma model inhibited tumor growth and prevented lung metastasis by reducing the frequency and immunosuppressive activity of CD4+CD25+ FOXP3+ regulatory T cells. © 2013 Landes Bioscience.

Author supplied keywords

Cite

CITATION STYLE

APA

Salatino, M., Dalotto-Moreno, T., & Rabinovich, G. A. (2013). Thwarting galectin-induced immunosuppression in breast cancer. OncoImmunology, 2(5). https://doi.org/10.4161/onci.24077

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free